These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32062312)

  • 21. Erratum to "Lipid metabolism and lung cancer" [Crit. Rev. Oncol. Hematol. 112, April (2017), 31-40].
    Salvador MM; de Cedrón MG; Rubio JM; Martínez SF; Martínez RS; Casado E; de Molina AR; Sereno M
    Crit Rev Oncol Hematol; 2019 Jan; 133():45. PubMed ID: 30661657
    [No Abstract]   [Full Text] [Related]  

  • 22. Erratum to "Lung cancer" [Crit. Rev. Oncol./Hematol. 27 (February (2)) (1998) 133-134].
    Repetto L; Granetto C; Venturino A; de Pas T; Giacone G
    Crit Rev Oncol Hematol; 2020 Mar; 147():102762. PubMed ID: 31694761
    [No Abstract]   [Full Text] [Related]  

  • 23. Erratum to "Cancer-related Fatigue in Adolescents and Young Adults: A Systematic Review of the Literature" [Crit. Rev. Oncol. Hematol. 118 (2017) 63-69].
    Nowe E; Stöbel-Richter Y; Sender A; Leuteritz K; Friedrich M; Geue K
    Crit Rev Oncol Hematol; 2017 Dec; 120():10-12. PubMed ID: 29198323
    [No Abstract]   [Full Text] [Related]  

  • 24. Erratum to "Role of radiation therapy in melanomas: Systematic review and best practice in 2015" [Crit. Rev. Oncol./Hematol. 99 (2016) 362-375].
    Fort M; Guet S; Husheng S; Calitchi E; Belkacemi Y;
    Crit Rev Oncol Hematol; 2016 Jun; 102():144. PubMed ID: 27160735
    [No Abstract]   [Full Text] [Related]  

  • 25. Erratum to "Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?" [Crit. Rev. Oncol. Hematol., 119 (November) (2017) 40-49].
    van der Weijst L; Surmont V; Schrauwen W; Lievens Y
    Crit Rev Oncol Hematol; 2017 Dec; 120():234-236. PubMed ID: 29055771
    [No Abstract]   [Full Text] [Related]  

  • 26. Erratum to "Role of radiation therapy in non-melanoma cancers, lymphomas and sarcomas of the skin: Systematic review and best practice in 2016" [Crit. Rev. Oncol./Hematol. 99 (2016) 200-213].
    Fort M; Guet S; Colson-Durand L; Auzolle C; Belkacemi Y
    Crit Rev Oncol Hematol; 2016 Jun; 102():145. PubMed ID: 27160736
    [No Abstract]   [Full Text] [Related]  

  • 27. Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].
    Occhipinti M; Brambilla M; Di Liello R; Ambrosini P; Lobianco L; Leporati R; Salvarezza M; Vitiello F; Marchesi S; Manglaviti S; Beninato T; Mazzeo L; Proto C; Prelaj A; Ferrara R; Della Corte CM; Lo Russo G; de Braud F; Ganzinelli M; Viscardi G
    Crit Rev Oncol Hematol; 2024 Sep; ():104521. PubMed ID: 39317528
    [No Abstract]   [Full Text] [Related]  

  • 28. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
    Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
    Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the resectability of pancreatic ductal adenocarcinoma: comparision of dual-phase helical CT arterial portography with conventional angiography.
    Jin Z; Li X; Cai L
    Chin Med Sci J; 2001 Mar; 16(1):40-5. PubMed ID: 12899347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
    Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
    BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
    Noda Y; Goshima S; Kawada H; Kawai N; Miyoshi T; Matsuo M; Bae KT
    AJR Am J Roentgenol; 2018 Jun; 210(6):1252-1258. PubMed ID: 29629801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in clinical research of pancreatic cancer: from "resection" to "cure"].
    Shen J; Guo SW; Jin G
    Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):72-77. PubMed ID: 30612395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
    Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
    Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non ductal-adenocarcinoma neoplasms of the pancreas.
    Serio G; Bortolasi L; Iacono C; Montresor E
    Chir Ital; 1999; 51(3):181-8. PubMed ID: 10793762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery.
    Zhang L; Zhang ZY; Ni JM; Li B; Chen FM; Jiang CJ; Hu CH
    J Comput Assist Tomogr; 2017; 41(3):394-400. PubMed ID: 27798447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline resectable pancreatic cancer.
    Hackert T; Ulrich A; Büchler MW
    Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiological evaluation of pancreatic ductal adenocarcinoma].
    Akai H; Otomo K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiral computed tomography assessment of resectability of pancreatic ductal adenocarcinoma: analysis of results.
    Procacci C; Biasiutti C; Carbognin G; Bicego E; Graziani R; Franzoso F; Pesci A; Megibow AJ
    Dig Liver Dis; 2002 Oct; 34(10):739-47. PubMed ID: 12469802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.